N@N

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

The article from MSN Money discusses why Catalyst Pharmaceutical (CPRX) is considered a strong momentum stock. It highlights that CPRX has shown significant positive momentum in its stock price, with a 1.86% increase last week, outperforming the Zacks Medical - Drugs industry which saw a 0.35% rise. Over longer periods, CPRX has also performed well, with a 13.86% increase in the last quarter and a 110.75% rise over the past year, compared to the S&P 500's 10.16% and 27.47% respectively. The stock's momentum is further supported by positive earnings estimate revisions; over the past two months, the consensus estimate for the full year has increased from $1.11 to $1.46. This upward trend in earnings estimates, combined with strong stock price performance, has led to CPRX receiving a Momentum Style Score of A and a Zacks Rank of #2 (Buy), making it an attractive option for investors looking for momentum stocks.

Read the Full MSN Article at [ https://www.msn.com/en-us/money/topstocks/here-s-why-catalyst-pharmaceutical-cprx-is-a-strong-momentum-stock/ar-AA1uRvLS ]